ICICI Prudential Pharma Healthcare & Diagnostics (P.H.D) Fund Growth Return

  • 1M
  • 3M
  • 6M
  • 1Y
  • 3Y
  • 5Y
This Fund:
Sensex:
BankFD:

Showing Funds Performance since Sep 07, 2020

ICICI Prudential Pharma Healthcare & Diagnostics (P.H.D) Fund Growth Fund Overview

Min. investment

SIP ₹100 & Lump. ₹5000

AUM (Fund size)

6,669 Cr

Lock In Period

N/A

Expense Ratio

2.41

Exit Load

1% of the applicable NAV - If units purchased or switched in from another scheme of the Fund are redeemed or switched out within 15 days from the date of allotment Nil.If units purchased or switched in from another scheme of the Fund are redeemed or switched out after 15 days from the date of allotment.

Benchmark

BSE Healthcare Total Return

Summary

ICICI Prudential Pharma Healthcare & Diagnostics (P.H.D) Fund Growth NAV is ₹41.41 as of 3 Jun, 2026. ICICI Prudential Pharma Healthcare & Diagnostics (P.H.D) Fund Growth has delivered 112.57% returns since its launch. The minimum SIP investment amount in ICICI Prudential Pharma Healthcare & Diagnostics (P.H.D) Fund Growth is ₹100. The AUM of ICICI Prudential Pharma Healthcare & Diagnostics (P.H.D) Fund Growth is ₹6,669 Cr. The expense ratio of the fund is 2.41%, and its benchmark is BSE Healthcare Total Return. The current exit load of the fund is 1% of the applicable NAV - If units purchased or switched in from another scheme of the Fund are redeemed or switched out within 15 days from the date of allotment Nil.If units purchased or switched in from another scheme of the Fund are redeemed or switched out after 15 days from the date of allotment.. In the last 1M months, ICICI Prudential Pharma Healthcare & Diagnostics (P.H.D) Fund Growth has delivered 5.48% returns.

ICICI Prudential Pharma Healthcare & Diagnostics (P.H.D) Fund Growth Calculate Returns

You would have got

close_grey_icon
No Data Found
Your Investment Amount
  • 1
  • 2
  • 3
  • 4
  • 5

Growth Review

DurationFund Return(%)Category Average(%)Category Best(%)
1M5.480.536.12
6M3.681.8010.64
1Y8.685.1816.68
3Y28.5816.28118.02

Portfolio Analysis

  • Equity: 96.75%
  • Debt: 3.25%
  • Others
As on: 2026-04-30
View allocation % by

1. Sun Pharmaceutical Industries Ltd.11.76%
2. Cipla Ltd.8.15%
3. Mankind Pharma Ltd.7.58%
4. Divi's Laboratories Ltd.6.06%
5. Dr. Reddy's Laboratories Ltd.5.94%
6. Biocon Ltd.5.81%
7. Cohance Lifesciences Ltd.4.44%
8. Lupin Ltd.3.80%
9. Medplus Health Services Ltd3.37%
10. Alkem Laboratories Ltd.3.24%
11. Syngene International Ltd.3.09%
12. Akums Drugs and Pharmaceuticals Ltd.2.02%
13. Pfizer Ltd.1.96%
14. Aurobindo Pharma Ltd.1.93%
15. Abbott India Ltd.1.88%
16. J.B.Chemicals & Pharmaceuticals Ltd.1.77%
17. Alembic Pharmaceuticals Ltd.1.74%
18. Alivus Life Sciences Ltd.1.72%
19. Entero Healthcare Solutions1.72%
20. Gland Pharma Ltd.1.51%
21. Blue Jet Healthcare Ltd.1.44%
22. Zydus Lifesciences Ltd.1.36%
23. Hikal Ltd.1.14%
24. Windlas Biotech Ltd.1.10%
25. Aarti Drugs Ltd.1.04%
26. Anthem Biosciences Ltd0.90%
27. Astrazeneca Pharma India Ltd.0.72%
28. FDC Ltd.0.66%
29. Shilpa Medicare Ltd.0.61%
30. Senores Pharmaceuticals Ltd0.21%

1. Thyrocare Technologies Ltd.1.88%
2. Metropolis Healthcare Ltd.1.31%
3. Nephrocare Health Services Ltd0.42%

1. Medi Assist Healthcare Services Ltd1.25%

1. Fine Organic Industries Ltd.1.15%

1. Sanofi Consumer Healthcare India Ltd1.03%

About Fund ICICI Prudential Pharma Healthcare & Diagnostics (P.H.D) Fund Growth

ICICI Prudential Pharma Healthcare & Diagnostics (P.H.D) Fund Growth managed by ICICI Prudential Mutual Fund,is a Healthcare & Pharmascheme with Assets Under Management of ₹6,669 Crore. The fund benchmarks its performance against the BSE Healthcare Total Return while maintaining an expense ratio of 2.41. Under the expert guidance of Dharmesh Kakkad ,the fund implements a disciplined investment approach aligned with its mandate. The scheme requires a minimum investment of ₹500 for SIP and ₹1,000 for lump sum investments, making it accessible to diverse investor profiles.

Fund Managers

Dharmesh Kakkad

.

Peer Comparison

Fund Name1Y3Y
This FundAditya Birla Sun Life Pharma & Healthcare Fund Growth11.492393.9166
This FundSBI Healthcare Opportunities Fund Growth10.771696.6321
This FundMirae Asset Healthcare Fund Growth15.01100.7295
This FundUTI Healthcare Fund Growth12.1521105.7476
This FundICICI Prudential Pharma Healthcare & Diagnostics (P.H.D) Fund Growth8.681112.5697

ICICI Prudential Pharma Healthcare & Diagnostics (P.H.D) Fund Growth FAQs

ICICI Prudential Pharma Healthcare & Diagnostics (P.H.D) Fund Growth's fund is managed by experienced SEBI-registered investment fund manager , who implements the fund's strategy through research-backed decisions while adhering to its stated objectives.

The expense ratio of ICICI Prudential Pharma Healthcare & Diagnostics (P.H.D) Fund Growth is 2.41. This expense ratio is calculated by dividing the fund's operating expenses by its net assets.

ICICI Prudential Pharma Healthcare & Diagnostics (P.H.D) Fund Growth’s fund performance is as follows:
  • 1 Month : 5.48%
  • 6 Months : 3.68%
  • 1 Year : 8.68%
  • 3 Years : 28.58%
Returns of ICICI Prudential Pharma Healthcare & Diagnostics (P.H.D) Fund Growth are updated daily based on NAV of ₹ 41.41 as on May 29,2026. Since inception, the return has been 112.57%.

You can invest in ICICI Prudential Pharma Healthcare & Diagnostics (P.H.D) Fund Growth through SIP with a minimum of ₹500 monthly or make a lump sum investment of a minimum ₹1,000. Additional purchase minimums vary by scheme.

The fund size (AUM) of ICICI Prudential Pharma Healthcare & Diagnostics (P.H.D) Fund Growth is ₹6,669 crore. It changes based on market performance, inflows, and outflows.

You can track your investment in ICICI Prudential Pharma Healthcare & Diagnostics (P.H.D) Fund Growth through our website, our Choice FinX mobile app, regular statements, and email updates. Our customer support team is available for queries.